Navigation Links
Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive

Researchers see hopes in a new therapy combining low dose steroid with lenalidomide, already// found effective against multiple myeloma.

Multiple myeloma is a cancer of plasma cells that are found in blood and bone marrow.

Survival chances improved considerably when a low dose of the steroid dexamethasone combined with lenalidomide was tried on patients with newly diagnosed multiple myeloma.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG).

The significance of the results lies in that a low dose regimen has been found to be more effective than the standard dose of dexamethasone.

Researchers found that patients in the study who received a lower dose regimen had a one-year survival of 96 percent compared to 86 per cent for patients treated in the case of those with the standard-dose of dexamethasone and lenalidomide.

In addition, there were fewer side effects associated with the low-dose dexamethasone and lenalidomide.

"These results have major implications for myeloma therapy," noted study chair Vincent Rajkumar. "The results of this study, particularly lenalidomide plus low-dose dexamethasone, are very positive and in my opinion represent a real step forward in the treatment of this disease."

The application of this effective and less toxic approach is expected to benefit many patients with myeloma.

In 2007, an estimated 19,900 people in the United States will be diagnosed with multiple myeloma and an estimated 10,790 people will die of the disease.
SRM
'"/>




Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care

Post Your Comments:
(Date:11/8/2009)... does not mean the battle is won," said Dr. Charma...SNewswire/ -- In a vote of 240-194, the Stupak-Ell...dment to prohibit abortion mandates and funding in...s United for Life Action President and CEO Dr. Cha...is a victory for the pro-life Americans across thi...
(Date:11/8/2009)...ov. 7 USAction this eve...for America Act, which will make health care more ... accountable and increase access to health care fo..., "Teddy Roosevelt, FDR and Harry Truman would ...rney. "Today,s vote ranks among our country,s prou...
(Date:11/8/2009)...ift Passage of H.R. 3961 to Secure the Stability o...wswire/ -- Statement Attributable to: J. James Roh.... ,, (Logo: http://www.newscom.com/cgi-bin/pr...assage of the House health reform bill, which will...hysicians and calls for swift passage of H.R. 3961...
(Date:11/8/2009)... House Passage of Health Care Reform Bill ,, ...prove coverage for all Americans ,, CHICAGO, N... States House of Representatives passed by a vote ...n that would strengthen Medicare for seniors and e...es millions of Americans out of affordable health ...
(Date:11/8/2009)... House Passage of Health Care Reform Bill ,, ...prove coverage for all Americans ,, BALTIMORE,...ght the United States House of Representatives pas...ould strengthen Medicare for seniors and end discr...ons of Americans out of affordable health coverage...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3
... there is a woman; much like the association betwe...tion for success. Some Older men need to ...new survey has revealed The woman could be a wife,...led into seeing one. Advising men to be m...
...d pressure and related kidney disease, the path t... for men , researchers say. They may end ...could be very different, says Dr. Jennifer C. Sull...n earlier than women and the increase in blood pre...
...amage as a result of professional boxing, until no...e risks for brain injury in amateur boxing, said ...a University Hospital, Goteborg, Sweden. F... fluid (CSF) of 14 amateur boxers. Boxers were tes...
...t new clinical tower and research at the Baltimore...ed a significant financial commitment to Johns Hop...n Zayed Al Nahyan, the president of the United Ara...Johns Hopkins Hospitals new cardiovascular and cri...
...es or simply investigate how organisms develop, s...iological science's toughest assignments: keeping ... Stem cells have notoriously finicky tastes, and...in morphing into specific cell types. Uni...
... inequalities in health services between rural and.... Chronic heart failure is an increasing p... population ages, and Australia has one of the hig...any health indicators, said Professor Henry Krum, ...
Other Medicine News:Health News:Cause of Gender Differences in Blood Pressure, Kidney Damage Under Study 2Health News:Cause of Gender Differences in Blood Pressure, Kidney Damage Under Study 3Health News:Does Amateur Boxing Cause Brain Damage? 2Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 2Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 3Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 2Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 3
(Date:11/6/2009)... YORK, Nov. 6 Keryx Biop...conference call on Tuesday, November 10, 2009 at 8...ancial results and business outlook for the remain... of the Company, will host the call. Keryx will a... press release to be issued prior to the call. ,...
(Date:11/6/2009)...ANTA, Nov. 6 GeoVax Lab...the Company"), an Atlanta-based, biopharmaceutical...used by HIV-1 (Human Immunodeficiency Virus) and o...quarter 2009 financial results and provided an ope...ident and Chief Executive Officer commented, "We a...
(Date:11/6/2009)... DIEGO, Nov. 6 California American... as "No Drugs Down the Drain" week for its San Die...ign sponsored by public and private agencies alike...cal pollution in our source water supplies. ,, ...mers are encouraged to drop off expired or unwante...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Cephalon Third Quarter 2009 Earnings Conference Call to be held Tuesday October 27 2009 at 5 3A00 p m EDT 58556 1Lumetra Announces Sale of Subsidiary IntegriGuard 58553 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 3Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 4Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 5
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: